← Eichor
Condition: Impaired Renal Function Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Impaired Renal Function

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
NA · 1 location(s) · Universidade Federal Fluminense · NCT07597005A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chro
Phase 2 · 1 location(s) · Institute of Medicinal Biotechnology, Chinese Academy of Med · NCT07496177Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667Dietary Potassium Liberalization in Pre-Dialysis Patients
NA · 2 location(s) · University of Manitoba · NCT05090865Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
Phase N/A · 1 location(s) · Odense University Hospital · NCT05266092Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury
Phase N/A · 1 location(s) · Dr. Gordon Boyd · NCT04722939The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients
Phase 4 · 1 location(s) · Cairo University · NCT06570187EndoForce Post Approval Study
Phase N/A · 2 location(s) · Phraxis, Inc. · NCT07146854Telemonitoring of Hypertensive Patients With Chronic Kidney Disease
NA · 1 location(s) · University of Alberta · NCT04098354NIRS Monitoring in the NICU and AKI
NA · 1 location(s) · NYU Langone Health · NCT07222722Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
NA · 2 location(s) · University of Avignon · NCT07269379Assessment of Renal Perfusion Using Ultrasound and Near-Infrared Spectroscopy in Patients Undergoing Minimally Invasive
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT07635160Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Phase 1 · 1 location(s) · Sparrow Pharmaceuticals · NCT07227922Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
NA · 2 location(s) · University of Pittsburgh · NCT06978127Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
Phase N/A · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07237451Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth
NA · 1 location(s) · Jérôme Bouchan · NCT07469540Hamburg Acute Renal Injury Study (HARIS)
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07338669Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes
Phase N/A · 1 location(s) · Aristotle University Of Thessaloniki · NCT07483879Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Fail
NA · 14 location(s) · Hospices Civils de Lyon · NCT05817539Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Phase N/A · 1 location(s) · Shanghai Changzheng Hospital · NCT07043166A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea
Phase 4 · 12 location(s) · Herlev and Gentofte Hospital · NCT06642272Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-R
Phase 4 · 1 location(s) · CAMC Health System · NCT04279457The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Populati
Phase N/A · 1 location(s) · Ain Shams University · NCT06755372REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Phase 3 · 8 location(s) · VA Office of Research and Development · NCT05931276Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Phase 1/Phase 2 · 2 location(s) · United Therapeutics · NCT06878560Equol and Vascular Function in Women With Chronic Kidney Disease
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT07194590Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Phase N/A · 3 location(s) · University of Virginia · NCT06595420A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · 71 location(s) · AstraZeneca · NCT07222917
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.